Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Redlands. Study-provided care at no cost to qualified participants.
Access non-small cell lung cancer specialists in Redlands at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-small cell lung cancer treatment provided free
This study is researching an experimental drug called fianlimab (also called REGN3767), combined with a medication called cemiplimab (also called REGN2810), individually called a "study drug" or collectively called "study drugs". The study is focused on patients who have advanced non-small cell lung cancer (NSCLC). The aim of the study is to see how effective the combination of fianlimab and cemiplimab is in treating advanced NSCLC, in comparison with cemiplimab by itself. The study is looking
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this non-small cell lung cancer clinical trial in Redlands, CA
If you're searching for non-small cell lung cancer treatment options in Redlands, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Redlands research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.